Search results
FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial...
StreetInsider· 6 days ago(NASDAQ: HUGE)(CSE: HUGE)(FRA:0K9A...building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that ...